Qiagen N.V. (ETR:QIA)

Market Cap	8.37B
Revenue (ttm)	1.85B
Net Income (ttm)	86.67M
Shares Out	n/a
EPS (ttm)	0.39
PE Ratio	96.53
Forward PE	17.95
Dividend	1.21 (3.22%)
Ex-Dividend Date	Jul 2, 2025

Volume	47,756
Average Volume	544,063
Open	38.73
Previous Close	38.27
Day's Range	38.67 - 38.96
52-Week Range	34.24 - 47.36
Beta	0.62
RSI	48.43
Earnings Date	Apr 28, 2025

About Qiagen

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1984
• Employees: 5,396
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: QIA

Financial Performance

In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.

Financial numbers in USD